Table 2. Health care utilizations and work incapacities associated with diagnoses of Campylobacter enteritis or sequelae over a 12-month period.
| Campylobacter enteritis (CE) | Sequelaea | |||||||
|---|---|---|---|---|---|---|---|---|
| Moderate CE (n = 6,336) | Severe CE (n = 3,609) | p value | Reactive arthritis (n = 12) | Guillain-Barré syndrome (n = 6) | Crohn’s disease (n = 143) | Ulcerative colitis (n = 185) | Irritable bowel syndrome (n = 337) | |
| Outpatient medical care [%] | ||||||||
| GP | 51.7 | 11.9 | <0.001 | 16.7 | 16.7 | 44.1 | 54.1 | 48.4 |
| pediatrician | 10.5 | 1.2 | <0.001 | 0.0 | 0.0 | 6.3 | 5.4 | 1.8 |
| internist | 25.1 | 4.7 | <0.001 | 8.3 | 66.7 | 38.5 | 30.8 | 43.3 |
| other physicians | 3.9 | 0.6 | <0.001 | 33.3 | 16.7 | 16.1 | 17.3 | 13.4 |
| provided in hospitals | 0.2 | 0.3 | 0.202 | 0.0 | 16.7 | 6.3 | 4.3 | 2.4 |
| Inpatient medical careb [%] | 0.0 | 100.0 | <0.001 | 25.0 | 66.7 | 7.7 | 13.0 | 2.1 |
| stays [md (min-max)] | 1.0 (1.0–2.0) | 1.0 (0.6–1.0) | 0.7 (0.4–1.0) | 0.9 (0.4–2.0) | 1.0 (0.4–3.0) | 1.0 (0.5–1.0) | ||
| days per stay [md (IQR, min-max)] | 5.0 (4.0–7.0, 1.0–53.0) | 6.0 (4.0–22.0, 4.0–22.0) | 21.0 (14.3–104.3, 13.0–131.0) | 7.5 (5.3–15.8, 2.0–20.0) | 8.0 (4.0–13.0, 2.0–90.0) | 5.0 (3.0–5.0, 2.0–7.0) | ||
| Rehabilitation [%] | 0.0 | 0.0 | 0.0 | 33.3 | 0.0 | 0.5 | 0.0 | |
| stays [md (min-max)] | 0.4 (0.4–0.4) | 0.5 | ||||||
| days per stay [md (min-max)] | 111.5 (61.0–162.0) | 20.0 | ||||||
| Prescribed medicationc [%] | ||||||||
| antibiotics | 13.1 | 8.7 | <0.001 | |||||
| analgesics/spasmolytics | 18.7 | 24.2 | <0.001 | |||||
| oral rehydration solution | 1.7 | 1.3 | 0.119 | |||||
| Incapacities for work [%d] | 18.9 | 57.5 | <0.001 | 25.0 | 50.0 | 30.2 | 31.1 | 16.4 |
| days [md (IQR, min-max)] | 8.0 (4.0–14.0, 1.0–247.0) | 3.0 (1.0–7.0, 1.0–207.0) | <0.001 | 3.0 (1.0–5.0, 1.0–5.0) | 128.7 (46.0–211.4, 46.0–211.4) | 5.0 (3.0–12.0, 0.6–162.0) | 5.5 (2.8–13.8, 0.5–144.5) | 2.0 (1.0–6.8, 0.6–38.0) |
The percentage of patients utilizing the respective service or of patients who were incapacitated for work (%) and median (IQR, min-max) number of days or stays of utilizing patients are given. Existing differences or associations depending on CE severity were examined using the Wilcoxon rank-sum or Chi-square test, respectively. IQR: interquartile range, md: median.
a Average health care utilizations associated with sequelae per 12 months were determined considering the individual time between the first and the last diagnosis of the respective sequela.
b Only hospitalizations with principal diagnoses were considered to be disease-associated and are displayed.
c Considered to be CE-associated according to national medical treatment guidelines, as prescriptions of medication are not directly diagnosis-linked in the claims data.
d Proportion of patients aged 15–64 years; days refer to patients incapacitated for work according to incapacity certificates; short-term absences might not have been recorded in the claims data.